about
L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamineContinuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasiaMetastatic renal adenocarcinoma produced by streptozotocin (NSC-85998)Antitumor activity of selected amino acid derivatives against various tumor systemsCis-dichlorodiammineplatinum (II) (NSC-119875): hearing loss and other toxic effects in rhesus monkeysThe Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a reviewClinical trials with 1-acetyl-2-picolinoylhydrazine (NSC-68626) in childrenPhase I. evaluation of cyclocytidine (NSC-145668)Phase I clinical trial of isophosphamide (NSC-109724)Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in miceCoordination complexes of platinum as antitumor agentsExperimental clinical cancer chemotherapy. Philosophy at the preclinical level.Effects of nonlinearity on subjective and objective analyses of hormone assay data.Treatment of far-advanced cancer with 5-fluorouracil, used alone and in combination with irradiation. Incidence and duration of remission and survival-time data in 223 patients.A manual on quantitative drug evaluation in experimental tumor systems. I. Background, description of criteria, and presentation of quantitative therapeutic data on various classes of drugs obtained in diverse experimental tumor systems.DATA-SUMMARY FORM FOR CLINICAL INVESTIGATIONS IN CANCER CHEMOTHERAPY.COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.Clinical phase I trial of inosine dialdehyde (NSC-118994).Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208).Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.HEMATOLOGIC EFFECT OF AN ETHYLENIMINE COMPOUND.MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED CANCER.AN EVALUATION OF AB-103 (NSC-37096) IN THE PALLIATIVE MANAGEMENT OF ADVANCED GASTROINTESTINAL CARCINOMA.COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER.CYCLOPHOSPHAMIDE (NSC-26271)-1 IN UNCOMMON MALIGNANT NEOPLASMS IN CHILDREN.HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY.PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065).PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.PHASE I STUDIES OF PYRAZOLE (NSC-45410).CLINICAL STUDY OF O-PHENYLENEDIAMINE (NSC-5354) IN MELANOMA.5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of solid tumors in children.Initial clinical study of tris(2,2-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132).Phase I study of 5-azacytidine (NSC-102816) .Evaluation of dosage schedules of mitomycin C (NSC-26980) in children.
P1433
Q28315964-E3AC014D-4D21-46E2-8F42-5856FD35ECBCQ28317826-D2B518A9-ADD3-4A6E-8FBD-098B1EAC814EQ28319467-782C1A06-DC1B-404C-8E86-8F4F8962EB79Q28320192-F0822A5E-83BD-4C2C-AFED-83E51ED016BBQ28329795-A214F37D-8E1F-47A7-A457-705E0ACA70FBQ28336670-ED31DA9D-C93D-4A2C-991F-05A03E768F12Q28336760-FF292890-07CB-4E81-93D2-FD70D147EFFAQ28336764-DEA02852-5FB5-4D88-84D6-530679697450Q28336843-0B049179-5567-4689-B903-61AD4BF59885Q28340856-C955C621-CB1F-488F-B882-1ED7AA62A8F6Q28340858-D5A5F51D-9BEB-48B3-9675-6501886E342EQ30334665-8995B46F-1135-4C0E-9D79-39F07AF6DF81Q30848682-C72E6CF9-4F78-46CD-B7B7-B63320E46974Q30855318-8026B0D6-97A7-4D5C-A7C9-FB1230BEE564Q30855601-A56FF74D-ECA4-4855-A43D-7795374FE09FQ30867535-F568B6E0-34C7-4205-B6E2-0E8E4A1287B3Q33192386-B68AFCF6-D558-4204-BAA2-6888F71508C0Q33277137-47F64928-6543-4119-9B50-1DF85CAE21AFQ33333925-F21A9E55-05A9-4D8E-9F93-5EF853F4ED60Q33334254-354F2C25-E42B-489C-9676-1E8A7BFE3924Q33335016-9C29015E-4A8D-4FF1-939C-C8F8A199FFDCQ33335019-D53DAA8E-1A84-4810-98E1-4498EE9FE5FCQ33342629-6DF8F0CB-6342-4EBF-A7C5-113FE47933ACQ33342632-61625BF4-10CB-407A-87F2-BB2BE81966C2Q33342636-F2AE9D3C-C65A-4738-B0C3-940CA9BAA515Q33354229-A70007B1-3FB9-4979-A420-0E39CF8F8FB3Q33354409-DCA31E54-0574-4C54-B9F3-19D5BDCA0C98Q33354412-66966944-4D78-4D19-B221-1BE42489A495Q33355025-A34DE97F-8CC1-47B5-89C8-5B5206983706Q33355028-047EC617-54E9-4CF4-A6A5-8355C3AA41A7Q33355457-FB61A740-8DCF-4A38-8577-190DA4028533Q33355460-F772D469-2128-471D-B49E-195D33296E7FQ33355462-F9070615-5AA3-4B11-A0F8-D2321CBAA278Q33355465-44F77391-3D33-4CDA-907D-586F9DB920ECQ33355958-80D48EA3-2F24-484F-9140-BEF92029C953Q33356071-455952DD-FD6D-442E-B2E5-53D9AA98A308Q33371660-2584A263-36D2-4730-A3E9-1E3B8DF763C7Q33382257-9203C602-28E3-4104-B695-32FA658F234FQ33382259-8DE3DA81-E435-4D82-956A-B3CFBBF7AF67Q33461094-E0EC8E1B-C249-4A19-AB96-00F93C86CCAA
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Cancer chemotherapy reports
@ast
Cancer chemotherapy reports
@en
Cancer chemotherapy reports
@es
Cancer chemotherapy reports
@it
Cancer chemotherapy reports
@nl
type
label
Cancer chemotherapy reports
@ast
Cancer chemotherapy reports
@en
Cancer chemotherapy reports
@es
Cancer chemotherapy reports
@it
Cancer chemotherapy reports
@nl
altLabel
Cancer Chemother Rep
@en
prefLabel
Cancer chemotherapy reports
@ast
Cancer chemotherapy reports
@en
Cancer chemotherapy reports
@es
Cancer chemotherapy reports
@it
Cancer chemotherapy reports
@nl
P1055
P1156
P1476
Cancer chemotherapy reports
@en